Frequency of Factors Leading to Thrombocytopenia Presenting to a Tertiary Care Hospital
DOI:
https://doi.org/10.54112/bcsrj.v6i6.2158Keywords:
Thrombocytopenia; Sepsis, Drug-Induced Thrombocytopenia, Heparin-Induced Thrombocytopenia, Central Venous CathetersAbstract
Thrombocytopenia is a common haematological abnormality encountered in hospitalised patients and is associated with increased morbidity and mortality. Identifying the underlying factors contributing to thrombocytopenia is essential for timely intervention and prevention of complications. Objective: To determine the frequency of factors leading to thrombocytopenia in patients presenting to a tertiary care hospital. Methods: This cross-sectional study included 127 patients aged 18–80 years presenting with thrombocytopenia (platelet count <150,000/µL) from 12-02-2025 to 12-05-2025. Patients with autoimmune disorders, pregnancy, and known platelet disorders were excluded. All participants were evaluated for potential etiological factors, including sepsis, invasive catheter use, antibiotic exposure, and heparin-induced thrombocytopenia. Data were analysed using SPSS version 21, and results were expressed as frequencies and percentages. Results: The mean age of the patients was 51.9 ± 18.4 years, with 65 (51.2%) males and 62 (48.8%) females. Diabetes mellitus was present in 35 (27.6%) patients, while 46 (36.2%) had hypertension. Antibiotic exposure was the most frequent factor associated with thrombocytopenia, identified in 70 cases (55.1%), followed by sepsis in 54 cases (42.5%), invasive catheter use in 29 cases (22.8%), and heparin-induced thrombocytopenia in 21 cases (16.5%). Conclusion: Antibiotic exposure and sepsis were the most common factors associated with thrombocytopenia in patients presenting to a tertiary care hospital. Awareness and early identification of these factors may help reduce complications and improve patient outcomes.
Downloads
References
Ashworth I, Thielemans L, Chevassut T. Thrombocytopenia: the good, the bad and the ugly. Clin Med (Lond). 2022;22(3):214-217. https://doi.org/10.7861/clinmed.2022-0142
Raadsen M, du Toit J, Langerak T, van Bussel B, van Gorp E, Goeijenbier M. Thrombocytopenia in virus infections. J Clin Med. 2021;10(4):877. https://doi.org/10.3390/jcm10040877
Scharf RE. Thrombocytopenia and hemostatic changes in acute and chronic liver disease: pathophysiology, clinical and laboratory features, and management. J Clin Med. 2021;10(7):1530. https://doi.org/10.3390/jcm10071530
Petito E, Gresele P. Immune attack on megakaryocytes in immune thrombocytopenia. Res Pract Thromb Haemost. 2024;8(1):102345. https://doi.org/10.1016/j.rpth.2023.102345
Marini I, Zlamal J, Faul C, Holzer U, Hammer S, Pelzl L, et al. Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan. Haematologica. 2021;106(1):196-207. https://doi.org/10.3324/haematol.2019.236117
Rajashekaraiah V, Berikai Ananthakrishna A. Drug-induced thrombocytopenia–etiology and alternative therapeutic approaches. Eur J Clin Exp Med. 2023;30(3):617-626. https://doi.org/10.15584/ejcem.2023.3.15
Rasizadeh R, Ebrahimi F, Kermanshahi AZ, Sorkhabi AD, Sarkesh A, Nahand JS, et al. Viruses and thrombocytopenia. Heliyon. 2024;10(6):e27844. https://doi.org/10.1016/j.heliyon.2024.e27844
Zeb S, Mehmood Z, Aurangzeb L, Mushtaq F. Understanding the significance of thrombocytopenia in COVID-19 patients: a comparative analysis with normal platelet counts. Pak J Chest Med. 2023;29(4):432-438. https://doi.org/10.1996/pjcm.v29i4.884
Batool U, Saeed A, Abbasi A, Rabbani B, Aamir R, Zehra T. B12 deficiency: hidden player in dengue-induced thrombocytopenia. Pak J Health Sci. 2024;5(12):194-199. https://doi.org/10.54393/pjhs.v5i12.2378
Ellahi A, Khan MW, Shahid S, Usman J, Ikran H, Naveed S. Thrombocytopenia in pregnancy: a cross-sectional study in Northern Pakistan. Pak Armed Forces Med J. 2022;72(3):1013-1017. https://doi.org/10.51253/pafmj.v72i3.7048
Crickx E, Mahévas M, Michel M, Godeau B. Older adults and immune thrombocytopenia: considerations for the clinician. Clin Interv Aging. 2023;18:115-130. https://doi.org/10.2147/CIA.S369574
Ahmad MH. Prevalence and risk factors of thrombocytopenia in a medical intensive care unit in Egypt. Acta Sci Med Sci. 2022;6(6):96-101. https://doi.org/10.31080/ASMS.2022.06.1274
Siddiqui W, Hereker FF, Kazi AN, Ahmed M. Frequency of thrombocytopenia and its association with short-term outcomes among ICU patients. Nat J Health Sci. 2025;10(2):95-100. https://doi.org/10.21089/njhs.102.009596
Idris M, Farid J, Khan MA, Gul N, Moeen S. Frequency distribution of causes and severity of thrombocytopenia in patients of all age groups. Med Forum Mon. 2021;32(6):34-37.
Altyar AE, Kamran SH, Batool H, Saleem Z, Shahid N. Investigating thrombocytopenia in Meropenem-treated patients: a cross-sectional observational study. Futur J Pharm Sci. 2025;11:98. https://doi.org/10.1186/s43094-025-00858-8
Arepally GM, Padmanabhan A. Heparin-induced thrombocytopenia: a focus on thrombosis. Arterioscler Thromb Vasc Biol. 2021;41(1):141-152. https://doi.org/10.1161/ATVBAHA.120.315445
Luman A, Quencer KB, Kaufman C. Pre-procedure thrombocytopenia and leukopenia association with risk for infection in image-guided tunneled central venous catheter placement. Tomography. 2022;8(2):627-634. https://doi.org/10.3390/tomography8020052
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Noor Ul Wahab, Muhammad Usman, Asif Khan, Muhammad Bilal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


